Classification
- Anatomical main groupJAnti-infectives for systemic use
- Therapeutic subgroupJ07
- Pharmacological subgroupJ07B
- Chemical subgroupJ07BBInfluenza vaccines
- Chemical substanceJ07BB02Influenza, purified antigen
Where it is registered
Each register with its number of medicines and a few of them.
European Union
EMA · 1 medicine
All medicines with Trivalent influenza vaccine
Every register, a page at a time. Strengths and packs are on each medicine’s page.
9 results
| Medicine | Register | Strength | Form | Status | Holder |
|---|---|---|---|---|---|
| Flumist Trivalent Influenza Intranasal VaccineCombination | Singapore | 7.0 ± 0.5 log10 FFU/dose + 7.0 ± 0.5 log10 FFU/dose + 7.0 ± 0.5 log10 FFU/dose | spray | Authorised | Astrazeneca Singapore Pte LTD |
| Supemtek | European Union | Authorised | Sanofi Winthrop Industrie | ||
| FluzoneCombination | Canada | 15 MCG / 0.5 ML + 15 MCG / 0.5 ML + 15 MCG / 0.5 ML | Suspension | Marketed | Sanofi Vaccines Canada LTD. |
| FluzoneCombination | Canada | 15 MCG / 0.5 ML + 15 MCG / 0.5 ML + 15 MCG / 0.5 ML | Suspension | Marketed | Sanofi Vaccines Canada LTD. |
| Fluzone High-DoseCombination | Canada | 60 MCG / 0.5 ML + 60 MCG / 0.5 ML + 60 MCG / 0.5 ML | Suspension | Marketed | Sanofi Vaccines Canada LTD. |
| FluviralCombination | Canada | 15 MCG / 0.5 ML + 15 MCG / 0.5 ML + 15 MCG / 0.5 ML | Suspension | Marketed | Id Biomedical Corporation of Quebec |
| FluzoneCombination | Canada | 7.5 MCG / 0.25 ML + 7.5 MCG / 0.25 ML + 7.5 MCG / 0.25 ML | Suspension | Cancelled | Sanofi Pasteur INC |
| FluzoneCombination | Canada | 15 MCG / 0.5 ML + 15 MCG / 0.5 ML + 15 MCG / 0.5 ML | Suspension | Cancelled | Sanofi Pasteur INC |
| Fluzone Trivalent Whole Virion | Canada | 45 MCG / 0.5 ML | Liquid | Cancelled | Aventis Pasteur INC. |